RecruitingPhase 2NCT07517575

Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
R-Pharm International, LLC
Principal Investigator
Mikhail Samsonov
R-Pharm
Intervention
OKZ q4w(drug)
Enrollment
71 target
Eligibility
2-17 years · All sexes
Timeline
20232030

Study locations (14)

Collaborators

R-Pharm · Keystat, LLC · Exacte Labs LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07517575 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials